Cannara Biotech Inc (LOVE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 02-2021 | 11-2020 | 08-2020 | 05-2020 | 02-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 751 | 708 | 723 | 553 | 725 |
| Accounts receivable | -397 | -81 | 241 | 42 | 658 |
| Other Working Capital | -1,057 | -2,152 | 283 | -415 | 1,271 |
| Other Operating Activity | -802 | -1,966 | -3,710 | -2,231 | -4,081 |
| Operating Cash Flow | $-1,505 | $-3,491 | $-2,463 | $-2,051 | $-1,426 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -379 | -859 | -798 | -1,150 | -945 |
| Purchase Sale Intangibles | 0 | 0 | 0 | 20 | -96 |
| Other Investing Activity | 11 | 15 | 27 | 70 | 97 |
| Investing Cash Flow | $-368 | $-844 | $-771 | $-1,080 | $-944 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,000 | 1,000 | 0 | 0 | 0 |
| Debt Repayment | -156 | -187 | -156 | -157 | -155 |
| Other Financing Activity | -353 | -192 | -64 | -120 | 137 |
| Financing Cash Flow | $2,491 | $621 | $-220 | $-277 | $-18 |
| Exchange Rate Effect | 41 | 14 | 87 | -12 | -17 |
| Beginning Cash Position | 4,071 | 7,771 | 11,139 | 14,560 | 16,964 |
| End Cash Position | 4,731 | 4,071 | 7,771 | 11,139 | 14,560 |
| Net Cash Flow | $619 | $-3,714 | $-3,455 | $-3,409 | $-2,388 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,505 | -3,491 | -2,463 | -2,051 | -1,426 |
| Capital Expenditure | -664 | -859 | -1,289 | -1,150 | -1,411 |
| Free Cash Flow | -2,169 | -4,351 | -3,752 | -3,201 | -2,838 |